Study looks at treatment intensification in youth with type 1 diabetes

01/29/2013 | PhysiciansBriefing.com

About 51.7% of youths with type 1 diabetes transitioned to a more intensive insulin treatment in three years, while 44.7% did not change and 3.6% moved to a less intensive therapy, a study indicated. Shifting to a more intensive treatment was more likely in younger patients, non-Hispanic whites and participants from families with private insurance and higher income and parental education levels, researchers wrote in Diabetes Care.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA